FDA NDC Directory · JSON-LD · Markdown

Sodium Polystyrene Sulfonate

NDC 55154-7353 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic namesodium polystyrene sulfonate
Labeler / ManufacturerCardinal Health 107, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA087859
Dosage form / routeSUSPENSION · ORAL RECTAL
Active ingredientsSODIUM POLYSTYRENE SULFONATE (15 g/60mL)
Marketing started19830101
Package count1

External sources

Source: openFDA. Public-domain (CC0).